Description

L-Arginine Mono[4-(1,3-Dihydro-1-Oxo-2H-Isoindol-2-Yl)-α-Methylbenzeneacetate] is a specialized pharmaceutical salt form of the essential amino acid L-Arginine, designed to enhance stability, bioavailability, and handling characteristics. This compound is critical for formulators seeking to leverage the therapeutic benefits of L-Arginine, such as nitric oxide production and vascular support, in a more robust and processable form. It is primarily utilized by the pharmaceutical and nutraceutical industries for the development of advanced solid dosage forms, including tablets and capsules, where consistent purity and reliable performance are non-negotiable.

Application

• Pharmaceutical Intermediates: Serves as a key active pharmaceutical ingredient (API) or precursor in the synthesis of cardiovascular and metabolic drugs.
• Nutraceutical Formulations: Incorporated into high-performance dietary supplements targeting endothelial function, blood flow, and athletic performance.
• Solid Dosage Development: Ideal for direct compression or granulation processes in tablet manufacturing due to its improved physical properties over base L-Arginine.
• Research & Development: Used in biochemical and pharmacological research to study nitric oxide pathways, amino acid transport, and drug delivery systems.
• Cosmeceuticals: Potential application in topical formulations aimed at skin rejuvenation and anti-aging due to its role in collagen synthesis and circulation.

Basic Information

Product Name	L-Arginine Mono[4-(1,3-Dihydro-1-Oxo-2H-Isoindol-2-Yl)-α-Methylbenzeneacetate]
CAS No.	98072-23-2
Molecular Formula	C24H30N4O5
Molecular Weight	454.52 g/mol
Synonyms	L-Arginine, 2-[[(4S)-4-amino-4-carboxybutyl]amino]-5-(diaminomethylideneamino)pentanoic acid compound with 2-[4-(2-methyl-2-phenylacetyl)phenyl]isoindoline-1,3-dione (1:1); Arginine Phthalimidomethyl Phenylacetate Salt; L-Arginine Salt of 4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-α-methylbenzeneacetic Acid; 98072-23-2; UNII-9VXA7B1FJ6
EINECS	Contact for details

Quality Control

Our L-Arginine Mono[4-(1,3-Dihydro-1-Oxo-2H-Isoindol-2-Yl)-α-Methylbenzeneacetate] is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure it meets high-purity standards suitable for pharmaceutical development. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with every shipment. We support compliance with cGMP, ICH Q7 guidelines, and relevant pharmacopeial standards (USP/EP) upon request for specific grades.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive); the container must be kept tightly sealed after opening to prevent degradation due to moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Related Substances (HPLC)	Total impurities ≤ 1.0% Any single impurity ≤ 0.5%
Optical Rotation	[α]20/D: +21.0° to +25.0° (c=1 in H2O)

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.